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Abstract: Dyspnea, a symptom limiting exercise capacity in patients with COPD, is associated 
with central perception of an overall increase in central respiratory motor output directed 
preferentially to the rib cage muscles. On the other hand, disparity between respiratory motor 
output, mechanical and ventilatory response of the system is also thought to play an important 
role on the increased perception of exercise in these patients. Both inspiratory and expiratory 
muscles and operational lung volumes are important contributors to exercise dyspnea. However, 
the potential link between dyspnea, abnormal mechanics of breathing and impaired exercise 
performance via the circulation rather than a malfunctioning ventilatory pump per se should not 
be disregarded. Change in arterial blood gas content may affect dyspnea via direct or indirect 
effects. An increase in carbon dioxide arterial tension seems to be the most important stimulus 
overriding all other inputs from dyspnea in hypercapnic COPD patients. Hypoxia may act 
indirectly by increasing ventilation and indirectly independent of changes in ventilation. A 
greater treatment effect is often achieved after the addition of pulmonary rehabilitation with 
pharmacological treatment.
Keywords: arterial blood gases, bronchodilation, lung volumes, pulmonary rehabilitation, 
vascular factors
No natural phenomenon can be adequately studied in itself alone, but to be understood 
must be considered as it stands connected with all nature.
(Sir Francis Bacon 1561–1626)
Preface
Contribution to our understanding of the nature and the mechanisms of dyspnea 
evolved in the last two centuries. Although the relationship was never formally speci-
ﬁ  ed discomfort was assumed to accompany respiratory muscle activity. Hypothesis 
and theories of dyspnea thus becomes synonymous with the factors controlling the 
extremes of respiratory muscle activity with expiratory muscle activity and discomfort 
now being controlled by the same factors. In his introduction to the “Breathlessness 
symposium” held in Manchester (1995), Julius H Comroe predicted that none of the 
speakers would deal directly with dyspnea: instead they would present only what they 
understood-the control of breathing, circumstance in which dyspnea may occur. In the 
event Comroe was largely right. Few contributors dealt with sensory aspects of the 
subjects, and what sensory physiology there was naïve (J.B. Howell 1992).
In the quarter of the last century since that symposium, things changed greatly as 
the contributions to the Moran Campbell Symposium held in Hamilton (1991) testiﬁ  ed. 
Both investigators and clinicians have adopted the attitude of sensory physiology and 
the methods of psychophysics. Also, the main related topic concerned the respiratory 
muscles rather than the control of breathing. In both of these changes the inﬂ  uence 
on Moran Campbell was central.International Journal of COPD 2007:2(4) 430
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Introduction
Dyspnea is the major reason for referral to pharmacological 
treatment and respiratory rehabilitation programs in patients 
with chronic obstructive pulmonary disease (COPD) (ATS 
1999; Trooster et al 2005). Dyspnea characterizes a sub-
jective experience of breathing discomfort that consists 
of qualitatively distinct sensations that vary in intensity. 
The experience derives from interactions among multiple 
physiological, psychological, social, and environmental 
factors, and may induce secondary physiological and behav-
ioral responses (ATS 1999). This deﬁ  nition underlines the 
importance of the different qualities covered by the term 
dyspnea, the involvement of integration of multiple source 
of neural information about breathing, and the physiological 
consequences.
In the following paragraphs we will try to answer the follow-
ing questions: (i) Which is the role of the respiratory muscles, 
operational lung volumes, vascular factors, arterial blood gases 
in dyspnea? (ii) Does competition between ventilatory and 
locomotor muscles for the available energy supplies increase 
with increasing work of breathing and, if any, does this affect 
dyspnea on exercise in COPD patients? (iii) What is the link 
between the language of exercise dyspnea and the underlying 
neurophysiological mechanisms? (iv) On what basis do bron-
chodilators reduce dyspnea intensity on exercise? and (v) How 
can rehabilitation program modulate exercise dyspnea?
Methods
A Medline search of articles published between 1960 and 
2006 was undertaken. A large body of scientiﬁ  c informa-
tion on exercise dyspnea has been published since the last 
1960 (Howell and Campbell 1966; Jones and Killian 1992). 
Starting from those miliar stones on origin and pathophysi-
ology of dyspnea we present the accumulate knowledge 
with particular emphasis on researches published in the last 
16 years. We restricted our presentation to COPD a disease 
state that compromises the energy supply, increases the work 
of breathing and decreases the respiratory muscle efﬁ  ciency 
and increase dyspnea during exercise.
Pathophysiology
Given the complexity of disturbances in respiratory mechan-
ics it is difﬁ  cult to be sure which alterations contribute most 
strongly to the sensation of dyspnea. This section is an 
attempt to identify the pathophysiological basis of dyspnea 
in patients with COPD. We shall consider the contribution of 
the respiratory muscles, operational lung volumes, vascular 
factors, and arterial blood gases to dyspnea.
The respiratory muscles
Respiratory effort
The intensity of the outgoing central motor command 
activating the muscular receptors and the copy of the 
increased motor command to the sensory cortex are con-
sciously appreciated as effort (El-Manshawi et al 1986; 
Leblanc et al 1988; O’Donnell et al 1997). Emphasis has been 
put on the importance of the relationships between demands 
placed on the inspiratory muscles and their capacity to 
generate pressure in understanding the perception of dyspnea 
experienced by patients with respiratory disorders (Leblanc 
et al 1988). The pressure per breath to maximal inspiratory 
pressure-generating capacity ratio increases during progres-
sive exercise in proportion to the sense of effort in patients 
with COPD in whom expiratory ﬂ  ow limitation enhances the 
recruitment of expiratory muscles (Potter et al 1971; Grimby 
et al 1976; Babcock et al 1995).When expiratory ﬂ  ow is 
limited, the enforced slowing of expiratory muscle velocity 
of shortening may increase expiratory pressure which may 
affect dyspnea (Kaiser et al 1997).
Respiratory muscle recruitment
Dyspnea may be the signal that rib cage inspiratory muscles 
are being recruited to assist the diaphragm (Babcock et al 
1995). With increased disease severity patients with COPD 
exhibit a shift in ventilatory muscle recruitment from the 
diaphragm to the rib cage, and the experienced degree of 
dyspnea may relate in part to this shift (Ward et al 1988, 
Martinez et al 1990). During unsupported arm exercise the 
respiratory muscles of the rib cage actively help maintain 
the position of the upper torso and extend arms. Hence, by 
decreasing their participation in respiration (Criner and Celli 
1988) contribute to the sensation of dyspnea (Celli et al 1986; 
Gigliotti et al 2005).
Respiratory muscle weakness
The intensity of dyspnea is greater in patients with cardio-
respiratory disorders and weak respiratory muscles because 
it takes more effort to drive a weak muscle than it does to 
drive a strong muscle. During exercise, for a given work load 
the weaker the inspiratory muscles the greater the dyspnea; a 
two-fold increase in their power output results in about 30% 
decrease in dyspnea (Hamilton et al 1995).
Inspiratory muscle fatigue
Fatigue is deﬁ  ned as a loss of the capability to generate skeletal 
muscle force and/or velocity which is accompanied by recov-
ery during rest (NHLB 1990). High intensity exercise does International Journal of COPD 2007:2(4) 431
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not cause diaphragmatic fatigue (Mador et al 2000) in most 
patients with COPD of moderate severity. Central inhibitory 
fatigue of the diaphragm, that is, a low level of activation of 
the muscle, does not take place in patients while exercising to 
exhaustion; dynamic hyperinﬂ  ation during exhaustive exercise 
reduces diaphragm pressure-generating capacity, while pro-
moting a high level of diaphragm activation (Sinderby et al 
2001) contributing to dyspnea (El-Manshawi et al 1986).
Operational lung volumes
The disparity between respiratory motor output and the 
mechanical response of the system is thought to play a major 
role in the increased perception of dyspnea in patients with 
COPD (O’Donnell and Webb 1993). Decrease in inspiratory 
capacity, a mirror of increase in dynamic hyperinﬂ  ation, 
along with a change in tidal volume and respiratory frequency 
account for 61% of the variance in rating of breathing difﬁ  -
culty in exercising patients with COPD (O’Donnell and Webb 
1993). Even though hyperinﬂ  ation maximizes tidal expiratory 
ﬂ  ow rates (Koulouris et al 1997) breathing at high lung vol-
umes has serious mechanical and sensory consequences: (i) 
tidal volume becomes positioned closer to total lung capacity 
where there is a signiﬁ  cant elastic loading to the inspiratory 
muscles (O’Donnell and Webb 1993; O’Donnell, Revill et al 
2001); (ii) shortening of the operating length of the inspira-
tory muscles, compromises their ability to generate pressure; 
(iii) inspiratory muscles are forced to use a large fraction of 
their maximal force generating capacity during tidal volume 
(Leblanc et al 1988; O’Donnell and Webb 1993; Gorini et al 
1996; O’Donnell, Revill et al 2001); and (iv) effort produc-
tion without an adequate concurrent volume or ﬂ  ow reﬂ  ects 
the neuro-ventilatory dissociation of the respiratory pump 
(O’Donnell and Webb 1993; O’Donnell, Revill et al 2001).
Although there is much evidence for an increase in 
end-expiratory-lung-volume (EELV) during exercise in 
many patients with COPD several more recent studies also 
indicate that this is not always the case (Calverley 2006): 
This is in keeping with earlier data suggesting that patients 
with COPD could also be limited by fatigue of their leg 
muscles when they exercised rather than simply by ventila-
tory factors (Hamilton et al 1995). Aliverti et al (2004) by 
measuring the total chest wall volume non-invasively using 
opto electronic pletismography have shown that exercise 
limitation and its attendant dyspnea is not necessarily asso-
ciated with dynamic pulmonary hyperinﬂ  ation in COPD. 
Unlike patients who hyperinﬂ  ate, a signiﬁ  cant number of 
patients (euvolumics) reduces abdominal volume preventing 
dynamic hyperinﬂ  ation. The most likely explanation was a 
difference between groups in their resting tidal expiratory 
ﬂ  ow limitation associated with hyperinﬂ  ation. Moreover, 
despite their better ﬂ  ow reserve, euvolumics reduced end-
expiratory-thoracic-volume (EETV) largely by reduction in 
the volume of their abdominal compartment. To do that they 
developed high intra-abdominal pressure rather than permit-
ting EETV to rise as in the hyperinﬂ  ators. Subsequent data 
during endurance exercise (Vogiatzis et al 2005) have shown 
two signiﬁ  cant patterns of change in EETV in patients who 
hyperinﬂ  ate during exercise: most patients exhibited a pro-
gressive signiﬁ  cant increase in EETV (early hyperinﬂ  ators) 
while in the remaining patients EETV remained unchanged 
up to 66% peak of work rate (Wpeak) and increased signiﬁ  -
cantly at Wpeak (late hyperinﬂ  ators). Note that in the two 
studies (Aliverti et al 2004; Vogiatzis et al 2005) the patterns 
of response – euvolumics vs hyperinﬂ  ators, and early vs 
late hyperinﬂ  ators – were associated with similar intensity 
of breathlessness. Prof PT Macklem (2005a) has recently 
focused on physiological differences between euvolumics 
and hyperinﬂ  ators:
“expiratory muscle recruitment, work of breathing, and 
competition between respiratory and locomotor muscles 
are all considerably less in hyperinﬂ  ators than in euvolu-
mics: they have learned to bypass the normal control of 
the respiratory muscles and hence their expiratory pressure 
remains low. [....] Without respiratory muscle recruitment 
dynamic hyperinﬂ  ation is inevitable if patients are sufﬁ  cient 
ﬂ  ow limited”
More recently, O’Donnell et al (2006) have demonstrated 
that dynamic hyperinﬂ  ation early in exercise allowed expi-
ratory ﬂ  ow limited patients to increase ventilation while 
minimizing respiratory discomfort; an advantage negated 
later – with EELV remaining constant – when tidal volume 
expanded to reach a critical low respiratory reserve volume 
of approximately 0.5 L below total lung capacity. After 
reaching this minimal inspiratory reserve volume dyspnea 
rose to intolerable level and reﬂ  ected the disparity between 
inspiratory effort (near maximal central respiratory drive) and 
the concurrent ﬁ  xed tidal volume response. Prof PT Macklem 
(2005) has recently focused on physiological differences 
between euvolumics and hyperinﬂ  ators.
Although “there can be no doubt that dynamic hyperinﬂ  a-
tion is a common and potent mechanism limiting exercise 
in COPD, a greater deal of research has show that patients 
are crippled as a result: recruit your respiratory muscles or 
not, patients with COPD are damned if they do and damned 
if they don’t” (Macklem 2005a).International Journal of COPD 2007:2(4) 432
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Vascular factors and ventilatory-locomotor muscle 
competition
Given the complexity of disturbances in respiratory mechan-
ics during exercise, it is difﬁ  cult to be sure which altera-
tions contribute most strongly to the sensation of dyspnea. 
Severe respiratory mechanical changes can be responsible 
for hemodynamic abnormalities and diminished exercise 
performance in patients with severe COPD. The implication 
is a potential link between abnormal mechanics of breath-
ing, impaired exercise performance, and dyspnea via the 
circulation rather than a malfunctioning ventilatory pump 
per se (Montes de Oca et al 1996).The consequence of the 
positive pressure swings during strenuous exercise is that 
mean intra-thoracic pressure during exercise could impede 
venous return and could impose a limitation to cardiovas-
cular response to exercise in patients, producing a situation 
similar to a Valsalva maneuver (Aliverti and Macklem 2001; 
Aliverti, Dellaca, et al 2005).
Locomotor and ventilatory muscles compete for avail-
able energy supplies with increase work of breathing in 
healthy subjects (Harms et al 2000). COPD could deprive 
the locomotor muscles of considerably more energy than in 
health because of the high cost of breathing at given level 
of ventilation (Levison and Cherniack 1968; Oelberg et al 
1998). This can establish ventilatory-locomotor muscle com-
petition for the available oxygen supply even at low exercise 
work loads (Aliverti and Macklem 2001; Simon et al 2001; 
Macklem 2005b). The conclusion is that the major limitation 
to exercise performance in patients with COPD who exercise 
beyond lactate threshold is an inadequate oxygen supply. 
This suggests that the relative ischemia of the respiratory 
muscles may contribute to the sensation of dyspnea (Aliverti 
and Macklem 2001).
Effects of interaction between ventilatory and 
circulatory mechanics on dyspnea during exercise
The mechanisms that couple ventilation to cardiac output 
during exercise are not well understood. Increased right 
ventricular after-load led Morrison et al (1987) to speculate 
that exercise limitation in COPD occurs as a result of the 
dynamic interaction between disordered right heart function 
and ventilation. High expiratory pleural pressure in COPD 
were reported indeed by Potter et al (1971), conﬁ  rmed by 
Dodd et al (1984), Montes de Oca et al (1996) and more 
recently by Aliverti et al (2004). The high expiratory pleural 
pressure interferes with venous return to right heart; and a 
high alveolar pressure increases pulmonary vascular resis-
tance and decreases both left heart ﬁ  lling and cardiac output 
(Aliverti and Macklem 2001). In presence of tidal expiratory 
ﬂ  ow the expiratory muscles might develop excessive pres-
sure in the vain attempt to increase ﬂ  ow; above the anaero-
bic threshold the perfusion of locomotor and respiratory 
muscles provides insufﬁ  cient oxygen to meet the demands 
(Aliverti and Macklem 2001). It seems that combination of 
high ventilatory demands and limitation of cardiac output 
(Aliverti, Dellaca et al 2005) – both caused by excessive 
expiratory pressure – can be potent factor limiting exercise 
performance in COPD.
Arterial blood gases
Hypercapnia and hypoxia drive breathing and, therefore, 
must inﬂ  uence the perception of the motor events. Recent 
evidence indicates that hypercapnia makes an independent 
contribution to dyspnea. Banzett et al (1989) showed the 
effect of increasing hypercapnia in mechanically ventilated 
quadriplegics in whom air hunger, as the dyspnea descrip-
tor, increased when end-tidal CO2 fraction (PetCO2) was 
surreptitiously raised by 7–11 mmHg. Similar results were 
obtained in ventilated healthy subjects (Banzett et al 1990). 
These studies contrast sharply with previous studies of 
Campbell et al (1967, 1969). They showed in two conscious 
volunteer physicians paralyzed with curare that the distress-
ing sensation normally associated with breath holding was 
completely absent when ventilation was suspended for over 
4 min and PaCO2 was allowed to rise. The observation that 
the less you breathe at given PCO2 the more breathless you 
ﬁ  ll argues against the Campbell’s criticism about a subject 
reporting the extreme air hunger at PacO2 of (only) 45 mmHg 
(Campbell 1992). Indeed, if arterial PCO2 is increased and 
breathing is not allowed to increase the subject experiences 
air hunger; likewise if PCO2 is held constant and tidal vol-
ume is decreased the subject experiences air hunger (Banzett 
2006).
Marin et al (1999) found that central chemoresponsive-
ness can explain a part of the variance in peak dyspnea in 
exercising COPD. As reported later by the same group central 
chemoresponsiveness explained about 28% of the variance 
in peak dyspnea, whereas no mechanical factors appeared to 
be involved (Montes de Oca et al 1998). Cloosterman et al 
(1998) found in patients with a wide range of obstructive pul-
monary disease performing an incremental cycle ergometer 
test that ventilatory muscle could be one of the important 
factors that correlated with the sensation of dyspnea in the 
group without CO2 retention; in contrast in the group with 
CO2 retention an increase in PaCO2 appeared to be the most 
important stimulus overriding all other inputs for dyspnea.International Journal of COPD 2007:2(4) 433
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Dyspnea may be generated by hypoxia but it is a much 
weaker stimulus of dyspnea. Nonetheless, more effort is 
required to generate any given muscle power as arterial 
oxygen content declines (eg, altitude or anemia). Change in 
oxygen content may affect dyspnea directly or indirectly. 
Hypoxia may act indirectly by increasing ventilation, and 
directly independent of change in ventilation in patients with 
COPD (Lane et al 1987). Swimburn et al (1984) showed simi-
lar relationship of ventilation with dyspnea whether COPD 
patients breathed air or 60% oxygen. The data suggested to 
the authors that hypoxia had no dyspnogenic effect, and that 
it caused dyspnea by stimulating ventilation.
How can we measure exercise dyspnea?
Quantitative assessment
Multidimensional instruments such as baseline dyspnea index 
(BDI) and transitional dyspnea index (TDI) and dyspnea 
components of chronic respiratory questionnaires provide 
comprehensive measurement of dyspnea as related to activi-
ties of daily living (Ambrosino and Scano 2004) .
BDI ad TDI questionnaires and chronic respiratory ques-
tionnaire (CRDQ) are valid, reliable and responsive instru-
ments (Mahler et al 1991). The BDI exhibits consistently 
high correlations with Medical Research Council (MRC) 
questionnaire, 6 min walking distance test (6 mWD), and 
quality of well being score (Mahler and Harver 1992). BDI 
and TDI adequately reﬂ  ects the beneﬁ  cial effects of pulmo-
nary rehabilitation programs (Mahler et al 1995).
Category ratio scale (CR-10) developed by Borg (1982) 
and visual analogue scale (VAS) could reproducibly 
measure symptoms during incremental and steady state 
exercise, and could detect the effect of drug interven-
tion. During cycle ergometry, power production or work 
performed are used as a stimulus (independent variable) 
for examining the dyspnea response (dependent variable) 
(Mahler et al 1991) assessed as Borg score. Continuous 
rating of dyspnea on response to a stimulus (ie, B2 agonist, 
work rate) during both incremental and constant work 
exercise offers some advantages to discrete rating of the 
symptom (Mahler et al 2005).
Qualitative assessment
In general the language of dyspnea complements physi-
ological measurements, both being essential to a compre-
hensive understanding of exercise tolerance and dyspnea. 
When requested to qualitatively assess their dyspnea on the 
base of the language of dyspnea (Simon et al 1990; Mahler 
et al 1996; Scano et al 2005) COPD patients describe the 
symptom as an increased respiratory work/effort at rest and 
unrewarded inspiration and/or inspiratory difﬁ  culty during 
exercise (O’Donnell et al 1997). The following, however, 
requires consideration: (1) cultural, socio-economic, lin-
guistic and educational backgrounds may inﬂ  uence the use 
of the language of dyspnea; and (2) whether improvement 
of the physiological derangements modiﬁ  es the language of 
dyspnea has yet to be deﬁ  ned.
Clinics
Physical examination
A male with a long history of heavy cigarette smoking, long 
been complaining of dyspnea during walking on the level. 
Patient sits forward while bracing their hands or elbows 
against a table or their knees. He manifests excessive inward 
motion of intercostal spaces during inspiration (Hoover sign) 
(Hoover 1920) and adopts a pursed lip breathing pattern 
(Casciari et al 1981; Breslin 1992; Bianchi et al 2004). Dur-
ing daily activity requiring the use of arms such as combing, 
dressing, washing, brushing and so on, he feels arm fatigue 
and greater dyspnea (Celli et al 1986; Criner and Celli 1988; 
Gigliotti et al 2005). Speaking, limited to a few words, 
increases dyspnea. On the other hand when requested to 
qualitatively assess their dyspnea on the basis of its language 
he describes increases of respiratory effort at rest, and denies 
chest tightness (Mahler et al 1996). If one acknowledges 
that asthma and COPD involve different pathophysiological 
derangements, one can also conceivably accept the possibility 
of different descriptors for the two conditions. Preliminary 
evidence has been provided that chests tightness character-
izes asthma more that COPD. The reported sensitivity of 
chest tightness was 0.86 for asthma and 0.07 for COPD: the 
speciﬁ  city was 0.69 and 0.64, respectively. The data indicate 
that over 86% of the patients who report chest tightness have 
asthma not COPD, and about 69% of patients who do not 
report chest tightness do not have asthma. Another descrip-
tor, I feel I cannot get a deep breath has high speciﬁ  city for 
COPD and fairly less for asthma and low sensitivity for both 
(Harver et al 2000).
Lung function test
The scenario is one of a typical ﬁ  xed obstructive pattern 
with severe decrease in FEV1 with hyperinﬂ  ation (increased 
functional residual capacity). Flow limitation is evident on 
the ﬂ  ow volume curve. Muscle weakness is coupled with 
an increased requirement of inspiratory pressure generation. 
Diffusion lung properties are remarkably reduced. Mild 
hypoxia and mild carbon dioxide retention are also found. International Journal of COPD 2007:2(4) 434
Stendardi et al
Measurement of dyspnea complements the clinical evalua-
tion of patients in who administration of standard dose of B2 
short acting agonist does not result in any signiﬁ  cant change 
in baseline pulmonary function despite less dyspnea.
Submaximal and maximal exertional testing
Patients walk a less than predicted timed distance and during 
incremental cycling exercise are less than predicted peak 
work rate, ventilation, and oxygen uptake; they also exhibit a 
decreased inspiratory capacity (ie, dynamically hyperinﬂ  ate), 
stop cardiopulmonary exercise test complaining either dys-
pnea or leg effort, or both (Hamilton et al 1995, 1996). The 
presence of high heart rate reserve and the absence of ventila-
tory reserve support the conclusion that they have ventilatory 
limitation. The clinical ﬁ  ndings, abnormal baseline normal 
function, and chest Xr pattern clearly differentiate these 
patients from subjects who complain of difﬁ  cult breathing 
with activities, but actually report higher rating for leg effort 
than dyspnea at submaximal and maximal exercise intensity 
(Mahler and Harver 1998). These ﬁ  ndings combined with a 
reduced peak oxygen uptake, and a normal breathing reserve 
(>30%) strongly single out individuals actually limited by 
deconditioning or musculoskeletal factors, rather than respi-
ratory disease (Mahler and Horowitz 1994).
There is strong evidence that either dyspnea or leg effort, 
or both limit exercise performance (O’Donnell and Webb 
1993; Hamilton et al 1996; O’Donnell et al 1997; Gigliotti, 
Coli et al 2003; Stendardi et al 2005). Leg fatigue appears 
to be more important in those with less COPD (Hamilton 
et al 1995).This is consistent with the belief that perception 
of effort to drive both respiratory and peripheral muscles 
plays an important role in limiting muscular performance 
(Hamilton et al 1996; Jones and Killian 2000; Scano et al 
2006). In this connection it has been postulated that in con-
ditions of moderate intensity of submaximal exercise when 
cardiac output is abnormally low and ventilatory work is high 
the effect of respiratory muscle load on maximal exercise 
performance might be due to the associated reduction in 
leg blood ﬂ  ow which increases both leg effort and intensity 
with which leg effort and dyspnea are perceived (Harms 
et al 2000). During prolonged submaximal exercise with a 
constant load both the perceived effort of breathing and the 
perceived effort of exercising the skeletal muscles gradually 
increase with time, eventually reaching the subject’s tolerable 
limit (Kearon et at 1991). During progressively increasing 
exercise both the perceived effort of exercising and the per-
ceived effort to breathing begin to increase at threshold of 
about 25% of maximal capacity and most subjects stop when 
they reach 4–7 on the Borg scale (Killian et al 1992). Patients’ 
data showing that after exercise rehabilitation programs a 
similar decrease in exertional dyspnea as in leg effort is asso-
ciated with unchanged inspiratory effort and maximal oxygen 
pulse (ie, the ratio of oxygen consumption to maximal heart 
rate) indicate other reasons for decreased perception being in 
play. On the other hand, the sedentary lifestyle of the patients 
with COPD contributes to peripheral muscle decondition-
ing, and there is evidence that peripheral muscle function is 
impaired in moderately severe COPD (Bernard et al 1998). 
Speciﬁ  c muscle weakness has been attributed to a possible 
COPD peripheral myopathy (Palange and Wagner 1999). 
This has been proposed on the basis of biochemical and 
istological changes in the quadriceps muscle of the patients. 
However, there is debate about the adequacy of oxygen 
delivery during exercise in these circumstance and whether 
this rather than any intrinsic abnormality explains the poor 
performance (Cuillard et al 1999; Richardson et al 1999). 
In this connection, strong evidence has been provided that 
exercise performance is limited by inadequate energy sup-
ply in COPD (Richardson et al 1999). These data suggested 
to the authors that reduced whole body exercise capacity in 
patients is the result of central restraints rather than peripheral 
skeletal muscle dysfunction and that the respiratory system 
is not the sole constraint to oxygen consumption.
It follows that treatment of airﬂ  ow resistance alone may 
not improve the exercise capacity of patients whose muscles 
are weak or produce excess lactate, unless muscle strength 
and aerobic capacity are concurrent improved (Maltais et al 
1996).
Treating exercising dyspnea
Pharmacological treatment
Optimal bronchodilatation can be seen as a ﬁ  rst step in 
improving exercise endurance and exertional dyspnea 
intensity in patients with COPD (Belman et al 1996; 
O’Donnell et al 1999; Mahler et al 2002; O’Donnell, Fluge 
et al 2004; O’Donnell Voduc 2004). Despite apparent non 
reversibility in spirometric parameter, long term adminis-
tration of once-daily inhaled anticholinergic demonstrates 
sustained improvement in inspiratory capacity, reduction in 
thoracic gas volume, and health outcomes (Celli et al 2003; 
O’Donnell, Fluge et al 2004; Maltais et al 2005). Although 
the precise neurophysiopathological mechanisms of dyspnea 
relief remains speculative the ability of bronchodilators to 
increase tidal volume represents the basis for reducing dys-
pnea intensity, or for alteration of its quality (O’Donnell, 
Voduc et al 2004). A number of bronchodilator studies have International Journal of COPD 2007:2(4) 435
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shown that the reduced dyspnea score on exercise at isotime 
correlates well with reduced operational lung volumes (ie, 
reduced end expiratory lung volume and increased inspiratory 
reserve volume) and improved breathing pattern (Celli et al 
2003; O’Donnell et al 2000). The evidence supports the idea 
that the beneﬁ  cial effect of bronchodilators on respiratory 
sensation of COPD patients potentially relates to increase 
in neuromechanical coupling of the ventilatory pump as a 
result of improved dynamic ventilatory mechanics (Belman 
et al 1996; O’Donnell et al 1999).
On the other hand, Aliverti, Rodger et al (2005) have 
recently shown that patients who increased their end expira-
tory abdominal compartmental volume during exercise after 
treatment with short acting B2 agonist were able to exercise 
for longer. In contrast, less hyperinﬂ  ated patients after the 
active drug reduced the abdominal compartmental volume 
in a fashion analogous to the euvolumic patients with COPD 
studied during incremental exercise (Aliverti et al 2004), and 
this paradoxically reduced their exercise capacity with higher 
isotime levels of dyspnea. The kinematic difference between 
improvers and worseners was the degree of expiratory muscle 
recruitment. The worseners were using the abdomen to pump 
the lung much more than the improvers. This requires coordi-
nated activity of the abdominal muscles and the diaphragm. 
As stated above excessive expiratory pleural pressure during 
ﬂ  ow-limited exercise acts as a Valsalva maneuver decreas-
ing cardiac output and producing the blood shift from trunk 
to extremities (Aliverti et al 2002, 2005; Iandelli et al 2002). 
It seems that a combination of high ventilatory demands and 
limitation of cardiac output (Levison and Cherniack 1968) both 
caused by excessive expiratory pressures can be a potent factor 
limiting exercise performance in COPD (Macklem 2005b).
There is no consensus regarding which exercise test to 
use to evaluate the functional impact of exercise dyspnea in 
patients with COPD (Palange et al 2000; Mann et al 2003). In 
particular, recent data indicate that endurance shuttled walk-
ing is a sensitive test to detect changes in exercise tolerance 
following bronchodilation. Difference in the occurrence of 
quadriceps muscle fatigue may explain in part the differ-
ent responsiveness to change between cycling and walking 
(Pepin et al 2005). Nonetheless, greater treatment effects 
(eg, improvement in exercise performance, symptoms, 
health-related quality of life) are often achieved only after the 
addition of pulmonary rehabilitation (Troosters et al 2005).
Pulmonary rehabilitation program
A six week outpatient pulmonary rehabilitation program 
includes education, breathing retraining and limb exercise 
training. Let ﬁ  rst consider how quantitatively and qualitatively 
does a patient modulate dyspnea at baseline by breathing 
retraining (Gigliotti, Romagnoli et al 2003). He/she sponta-
neously adopts a pursed lip breathing pattern (PLB). Despite 
improvement in gas exchange and efﬁ  cient ventilation, the efﬁ  -
cacy of PLB in relieving dyspnea varies greatly among patients 
(Troosters et al 2005) and is still a matter of debate (Spahija 
et al 2005). It has been recently shown that whatever the level 
of baseline hyperinﬂ  ation the effect of PLB on dyspnea relies 
upon its deﬂ  ationary effect on the chest wall abdominal com-
partment by an increased expiratory time (Bianchi et al 2004). 
Leaning forward (LF) attenuated patient’s dyspnea sensation. 
While standing position increases activation of the diaphragm 
and its force production, LF decreases both (Sharp et al 1980). 
The reason for the association of LF with less dyspnea lies in 
the common belief that dyspnea is linked to increased central 
motor command to the respiratory muscles (El-Manshawi 
et al 1986; Leblanc et al 1988; O’Donnell et al 1997); hence, a 
decreased respiratory muscle activation lowers dyspnea in this 
patient with partial restoration. During daily activities requiring 
the use of the arms patient exhibits increased sensations of arm 
effort and dyspnea. Bracing their arms partially restores the 
increased sensation of arm effort and dyspnea, whereas arm 
training program increases arm endurance at 7% maximal work 
rate, modulates dynamic hyperinﬂ  ation and lowers the Borg 
score of arm effort and dyspnea (Gigliotti et al 2005).
Let now consider how does exercise training modulate 
exercise dyspnea in patients with COPD. Although the 
physiologic mechanisms involved in the reduction of dyspnea 
after training are likely to be complex the following seems 
to play a major role: (i) cardiovascular factors, (ii) decreased 
ventilatory demand, (iii) decreased impedance to ventilatory 
muscle action, and (iv) non physiologic factors.
Cardiovascular factors
Ventricular dysfunction in addition to respiratory impairment 
may limit exercise performance in some patients with COPD 
(Mahler et al 1984). Inadequate 02 delivery is important in 
the impairment of exercise performance (Montes de Oca et al 
1996). Should these factors play a role in increasing exercise 
performance with exercise training we would observe an 
increased ratio of oxygen consumption to maximal heart rate 
(V02/HR), a non invasive estimate of stroke volume.
Decreased ventilatory demand
The decrease in both ventilation and carbon dioxide produc-
tion at standardized work rate indicates a decreased ventila-
tory demand. An increased aerobic capacity with exercise International Journal of COPD 2007:2(4) 436
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training is in line with a decrease in lactate production 
reported in older severely obstructed patients (Mahler and 
Horowitz 1994).
Decreasing impedance
Despite an unaltered ventilatory equivalent for carbon 
dioxide there is less Borg per unit change in ventilation 
after training. This would suggest an improved mechanical 
efﬁ  ciency which is usually accomplished by a decrease in 
dynamic elastance in association with decrease in dynamic 
hyperinﬂ  ation. Change in inspiratory capacity is a mirror of 
changes in dynamic end-expiratory-lung-volume. The role 
of dynamic hyperinﬂ  ation on dyspnea and that of increased 
respiratory muscle effort on the perception of inspiratory 
effort have been elucidated in the section of Pathophysiology. 
According to this scenario, exercise training reduced dyspnea 
by reducing the inspiratory effort, end-expiratory-lung-vol-
ume and respiratory rate. In turn it reduces the neuromuscular 
discoupling (ie, the ratio of respiratory effort to concurrent 
volume, or ﬂ  ow).
Non-physiologic factors
An increased tolerance to dyspnea may play an important 
role in the referred reduction of dyspnea at equivalent 
ventilation. Moreover, breathing retraining may actually 
improve the breathing pattern slowing respiratory rate, and 
indirectly contributing to modifying dyspnea (Hamilton et 
al 1996).
During leg exercise patients may also be given supple-
mental oxygen to improve exercise tolerance (Scano et al 
1982) and reduce exertional dyspnea (O’Donnell, D’Arsigny 
et al 2001). Most importantly, Borg score and ventilation 
fall proportionally; the slope in air and oxygen are super-
imposed indicating that the decrease in Borg is associated 
with reduced ventilatory demand. As a consequence of the 
improved aerobic metabolism, dyspnea decreases at iso-work 
load. Oxygen can also modify the strategy of respiratory 
muscle recruitment in these patients by increasing exercise 
performance of the diaphragm and unloading the accessory 
and abdominal muscles, with dyspnea being less (Criner and 
Celli 1987). This pattern was thought to prevent overload-
ing of other respiratory muscles (accessory inspiratory and 
abdominal muscles), with this resulting in less dyspnea. The 
results of a recent study in non hypoxemic COPD patients 
have shown that supplemental oxygen given during high-
intensity endurance training adds to the beneﬁ  t of training: 
endurance capacity, and dyspnea improves signiﬁ  cantly 
(Emtner et al 2003).
Finally, based on the ﬁ  ndings that unloading the respi-
ratory muscles by pressure support produces a substantial 
reduction in inspiratory effort and dyspnea (Maltais et al 1995; 
Dolmage et al 1997; Polkey et al 2000), and that a more pro-
nounced improvement is obtained in patients with respiratory 
muscle weakness the possibility has been considered for the 
application of inspiratory support to enhance training inten-
sity. Further studies, however, are needed to evaluate the 
effects of long term non invasive ventilation on change in 
daily dyspnea in these patients (Rossi and Hill 2000).
Lung volume reduction surgery (LVRS)
Surgical intervention for patients with severe bullous emphy-
sema who remain incapacitated by dyspnea despite optimal 
pharmacological therapy and pulmonary rehabilitation has 
emerged as a useful therapeutic option. LVRS has shown 
to improve pulmonary function and elastic recoil (Sciurba 
et al 1996), neuromechanical coupling of the diaphragm 
(Laghi et al 1998), exercise tolerance and quality of life, with 
reduction in the degree of airﬂ  ow obstruction and dynamic 
hyperinﬂ  ation (Martinez et al 1997). Much of the success of 
LVRS depends on patients selection criteria. Preoperative 
screening assessment and pulmonary rehabilitation should 
be used to select those patients most likely to beneﬁ  t from 
surgery.
In summary
The mechanisms contributing to dyspnea must be approached 
in an integrative manner. Respiratory muscle function and 
its relationship to metabolic and cardio–pulmonary variables 
during exercise identify some of the factors that limit exercise 
performance in patients with COPD. The identiﬁ  cation of 
other factors that contribute to variability in dyspnea during 
exercise could result in improvement in patient’s exercise 
capacity. Regardless of the relationships between respira-
tory and cardiovascular factors, a consistent amount of the 
variability of dyspnea remains unexplained. This is probably 
due to the fact that dyspnea is a subjective sensation which is 
dependent on the stimulus involved, the central processing, 
integration of many sensory inputs, the situational context in 
which it occurs, behavioral inﬂ  uences, and patient’s ability 
to describe sensations.
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